Evidence map›Paper›PMID 41869112›Full record

ReviewCureus2026

Nipah Virus in Focus: A Comprehensive Review of the Pathogenesis, Epidemiological Patterns, Diagnostic Advances, and Future Public Health Strategies.

Swathi Gurajala, Sai Saranya Gurajala

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Swathi GurajalaDepartment of Respiratory Care, College of Applied Medical Sciences, Imam Abdul Rahman Bin Faisal University, Jubail, SAU.
Sai Saranya GurajalaDepartment of Biology, International Indian School, Jubail, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nipah virus (NiV) remains one of the most concerning emerging pathogens due to its repeated spillover events, high mortality, and the absence of licensed vaccines or treatments. Its recurrence demonstrates that the ecological factors facilitating such outbreaks, including those linked to bat hosts, are still present. These patterns highlight the continued need for a coordinated One Health approach that connects human, animal, and environmental health. This review has four aims: (1) to summarize current understanding of NiV biology and pathogenesis, (2) to describe the epidemiological trends that shape how outbreaks unfold, (3) to assess recent advances in diagnostics, and (4) to highlight emerging strategies for prevention and control. Our narrative synthesis shows that NiV's ability to infect both the respiratory and nervous systems, combined with strong immune‑evasion mechanisms, contributes to rapid deterioration in many patients. Epidemiological evidence from South and Southeast Asia consistently links outbreaks to bat reservoirs, occasional intermediate hosts, and increasingly recognized person‑to‑person transmission. In diagnostics, improvements in rapid molecular tests, point‑of‑care tools, and serological platforms have expanded the ability to detect cases quickly in field settings. Promising progress is also being made in surveillance systems, ecological risk assessment, and the development of antiviral agents and vaccine candidates. By synthesizing current scientific and public health insights, this review underscores the need for sustained multidisciplinary strategies to mitigate future NiV threats.

Indexed as

antiviral therapeuticsepidemiologyhenipavirusmolecular diagnosticsnipah virusone healthpathogenesispoint‑of‑care testingvaccine developmentzoonotic infections

Identifiers

PMID41869112
PMCPMC13003242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.